A Randomized, Double-Blind, Active- and Placebo-Controlled, Crossover Study Assessing the Effect of 600 mg Gabapentin Enacarbil on Simulated Driving in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2013
At a glance
- Drugs Gabapentin enacarbil (Primary) ; Diphenhydramine
- Indications Restless legs syndrome
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; XenoPort
- 04 Nov 2011 Actual initiation date changed from Jul 2011 to Jun 2011 as reported by ClinicalTrials.gov.
- 04 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 04 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.